Request Deal Involvement
Forbion and Goldman Sachs Alternatives led a $372m Series D round in MapLight Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Ropes & Gray
legal advisors
Latham & Watkins
or
Principals
bidder
FORBION CAPITAL PARTNERS
bidder
T. ROWE PRICE GROUP INC
bidder
AVEGO BIOSCIENCE CAPITAL
bidder
NOVO HOLDINGS A/S
bidder
5AM VENTURES LLC
bidder
BLUE OWL CAPITAL
bidder
SANOFI SA
bidder
GOLDMAN SACHS ALTERNATIVES
target
MAPLIGHT THERAPEUTICS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite